In an immunohistochemistry analysis of 52 samples, 71.2% of the patients expressed high levels of XB130 in esophageal squamous cell carcinoma tissues, indicating that it may be a possible biomarker for diagnosis of esophagus cancer. This evidence concerns the gene AFAP1L2 and esophageal squamous cell carcinoma.